How Does This Health Insurer Operate?
Elevance Health is a U.S. health care company centered on health benefits and related services. It operates at large scale, serving members through insurance-style coverage offerings and supporting health-care delivery through affiliated capabilities. The business is built around managing medical costs, administering plans, and coordinating care networks. With a sizable public-market footprint, it sits in the middle of everyday health spending rather than discretionary demand.
Are Margins and Returns Holding Steady?
FundamentalsFor 2025 (reported in USD), revenue was USD 32.9 billion, alongside net income of USD 5.7 billion. Revenue grew 6.1% year over year, while trailing operating and net margins were 4.07% and 2.84%, respectively.
On the balance sheet, cash totaled USD 9.5 billion against USD 1.2 billion of total debt. Trailing ROE was 13.01%, highlighting how much equity the business uses to produce its earnings.
Is the Market Undervaluing These Returns?
DCF / MultiplesAt USD 311.53, the stock trades well below the range implied by discounted cash flow outcomes. The headline multiples reinforce the contrast: a 12.34 P/E and 10.58 EV/EBITDA reflect modest pricing on earnings, even as the 13.01% ROE indicates a business capable of generating solid equity returns relative to its margin profile.
Cheapness Reflects Mispricing
TakeawayThe pricing looks anchored to low margins, not equity compounding. The case works if returns on equity hold up. It also needs earnings to remain durable as revenue grows. If returns fade, the cheap multiple stops being cheap. That’s why the current gap looks like mispricing, not generosity.